0001824618-21-000003.txt : 20211025 0001824618-21-000003.hdr.sgml : 20211025 20211025101511 ACCESSION NUMBER: 0001824618-21-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211025 DATE AS OF CHANGE: 20211025 EFFECTIVENESS DATE: 20211025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cedilla Therapeutics, Inc. CENTRAL INDEX KEY: 0001824618 IRS NUMBER: 822647784 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-376252 FILM NUMBER: 211342471 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617- 281-5658 MAIL ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 D/A 1 primary_doc.xml X0708 D/A LIVE 0001824618 Cedilla Therapeutics, Inc. 245 FIRST STREET CAMBRIDGE MA MASSACHUSETTS 02142 617- 281-5658 DELAWARE None None Corporation true 2017 Alexandra Glucksmann 245 First Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Eli Casdin 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Dominik Naczynski 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Abbie Celniker 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Neil Exter 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Rosana Kapeller 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Chris Bowden 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Jake Simson 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b true 0001824618-21-000002 2020-09-09 false true false 0 82599996 82599996 0 false 24 0 0 0 false Cedilla Therapeutics, Inc. /s/ Alexandra Glucksmann Alexandra Glucksmann President and Chief Executive Officer 2021-10-25